Company / R&D Expense
USANA HEALTH SCIENCES INC R&D Expense History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$11.4M
FY2025
5-year range
$9.0M / $11.6M
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $11M to $11M over the past 3 years.
Based on SEC 10-K filings.
$11M in FY2025 with a 10-year CAGR of +8.5%.
Improved from $11M to $11M over the past 3 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +2.2%
- 10-Year CAGR
- +8.5%
Key checks
Key Insights
- 5-year CAGR of +2.2%, indicating consistent growth.
- In FY2025, r&d expense decreased 1.0% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2014.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.4M | -1.0% |
| FY2023 | $11.6M | +8.7% |
| FY2022 | $10.6M | +3.8% |
| FY2020 | $10.2M | +14.4% |
| FY2019 | $9.0M | +1.2% |
| FY2018 | $8.8M | +37.7% |
| FY2017 | $6.4M | +25.2% |
| FY2016 | $5.1M | +0.9% |
| FY2015 | $5.1M | +9.0% |
| FY2014 | $4.7M | +14.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026